♪ PODCAST: The next generation pricing & market access leaders with Adam Plich
Discussion about secrets to prepare and negotiate a new product launch with Teva's Former Vice President, Head of Pricing & European Market Access. Enjoy!
This article was provided by NextLevel Life Sciences
Related Videos
Presentation
Bridging the gap: Translating expedited regulatory approval into optimal reimbursement
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Regulations & Ethics
Availability: FREE
Speakers
Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting
Richard Macaulay
Principal Consultant
Parexel
Presentation
Market access & go-to-market strategy for transformative therapies: Changing our mindset
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
Speaker
Akshay Kumar
Principal Consultant
Huron Consulting Group, UK
Presentation
From PMPRB reforms to pCPA to National Pharmacare? Where is Canada heading when it comes to pricing and reimbursement of pharmaceuticals?
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Canada
Availability: FREE
Speaker
Dylan Lamb-Palmer
Manager, Pricing and Data Analytics
PDCI Market Access, Canada
Presentation
What it worth to you? Assessing value of product attributes through decision-analytic modeling
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
Speaker
Mason Russell
Vice President, Strategic Consulting (Life Sciences)
IBM Watson Health , USA
Presentation
Changing Trends in Real World Evidence
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker
Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK
Presentation
Early Access Programs – as a valuable component of market access and launch strategy
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Clinical
Availability: FREE
Speaker
Kieron Lewis
Global Business Development Director
Clinigen, UK
Presentation
Facilitating innovative pricing, value based reimbursement and personalised medicine using revolutionary blockchain technology
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, IT & Big Data
Availability: FREE
Speaker
Ahmed Abdulla
CEO
Digipharm, Switzerland
Presentation
Market access for (very high cost) rare disease or transformative therapies: changing our mindset
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Orphan Drugs
Availability: FREE
Speakers
Akshay Kumar
Principal Consultant
Pope Woodhead, UK
Eugenia Priedane
Senior Consultant
Pope Woodhead, UK
Presentation
Adaptive, Umbrella and Basket studies - What are they, Why are they needed, and how will payers receive them?
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
Speakers
Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting
Richard Macaulay
Principal Consultant, (Pricing and Market Access)
Parexel, UK
Presentation
Real world evidence: Opportunities and challenges with registry data
Related topics:
Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker
Tim Spelman
Senior Scientist
Synergus
Presentation
Future market access excellence: Enabling a dynamic organisation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
Speaker
Chris Easley
Head of Market Access Solutions
Pope Woodhead and Associates Ltd.
Presentation
What’s it worth to you? Assessing value of product attributes through decision-analytic modelling
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
Speaker
Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA
Presentation
Why a good strategy is not enough
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
Speaker
Janice Haigh
Vice President, Pricing & Market Access
PAREXEL
Presentation
Payer Trackers: A unique opportunity to shift the market access mindset from one of observing to one of shaping payer attitudes
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
Speaker
Santanu Das
Vice President
GFK, UK
Presentation
What is the Future for International Reference Pricing (IRP)
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
Speaker
Neil Palmer
Founder & Senior Consultant
PDCI Market Access
Presentation
Digital technology: An enabler of patient, payer and physician engagement
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care, Digital & Technology
Availability: FREE
Speaker
Giles Thurston
Head of Digital Solutions
Pope Woodhead and Associates Ltd.
Presentation
The impact of PROs on HTA decision-making
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
Speaker
Anke van Engen
Principal, Consulting Services
QuintilesIMS
Presentation
Is there a need for a centralised, European HTA agency and predictable, transparent European standards?
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
Speaker
Finn Boerlum Kristensen
Managing Director Science & Policy, Faculty of Health Sciences, University of Southern Denmark
Former EUnetHTA Executive, Committee Chairman and EUnetHTA Secretariat Director
Presentation
The Patient as the Payer: What drives patients’ willingness-to-pay?
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR, Patient-Centricity & Care
Availability: FREE
Speaker
Adrien Gras
Vice President Europe, Market Access
GFK, UK
Presentation
Bio-similar, but different: Establishing (or defending) value through Multi-Criteria Decision Analytic (MCDA) modelling
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
Speaker
Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA
Presentation
HTA in the changing development and regulatory landscape
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
Speaker
Anke van Engen
Principal, Consulting Services
QuintilesIMS
Presentation
HTA, funding & reimbursement of cell & gene therapies: A global perspective
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
Speaker
W. Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.
Presentation
Central and Eastern Europe: Diversity to tame, market access potential to unveil
Related topics:
Pharmaceutical/Biotech, MedTech, Europe, Market Access & HEOR, Central Eastern Europe
Availability: FREE
Speaker
Norbert Wilk
Director, Market Access Consulting
Arcana Institute, Poland
Presentation
Devising value-enhancing strategies for biosimilars: A conceptual framework
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Biosimilars
Availability: FREE
Speaker
Sotiris Rompas
Director
Boston Healthcare, USA
Presentation
Biologics, biosimilars, and interchangeable biologics: US update after first launch
Related topics:
Pharmaceutical/Biotech, USA, Market Access & HEOR, Biosimilars
Availability: FREE
Speaker
Kathleen E. Hughes
Vice President, Avalere Health, USA
Presentation
Blueprint for market access: Strategic insights from the regulatory and HTA review process
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
Speaker
Yin Ho
CEO
Context Matters Inc., USA
Presentation
Global review of innovative pricing arrangements: Shifting dynamics and new considerations
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
Speaker
Gustav Ando
Vice President of Life Sciences
IHS
Presentation
Understand the real drivers of HTA decision-making in oncology: What clinical and economic factors influence positive vs negative recommendations?
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR, Oncology
Availability: FREE
Speaker
Anke van Engen
Principal, Advisory Services, Quintiles, Netherlands
Presentation
Biosimilar, but different: Establishing (or defending) value through multi-criteria decision analytic (MCDA) modelling
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
Speaker
Mason W. Russell
MAPE, Vice President
Truven Health Analytics, USA
Presentation
Cell & gene therapies: A global perspective of HTA, funding & reimbursement challenges
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
Speaker
Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.
Presentation
Leveraging RWE to support market access: Lessons learned
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker
Mervyn D. Hall
Director of Market Access – Europe
Truven Health Analytics, UK